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Edited by Ned ManteiAbstract GRASP-1 is a neuronally enriched protein that inter-
acts with the AMPA-type glutamate receptor/GRIP complex.
GRASP-1 can be cleaved by Caspase-3 in both normal and
ischemic brains although the functional signiﬁcance of this cleav-
age remains elusive. We investigated signal transduction path-
ways that might lie downstream of GRASP-1 and found that
GRASP-1 potently activates JNK pathway signaling, with no
eﬀect on ERK signaling. Such JNK pathway activating activity
requires binding of GRASP-1 to both JNK and the upstream
JNK pathway activator MEKK-1. Furthermore, mutations that
prevent Caspase 3-cleavage of GRASP-1 dramatically inhibit
the JNK pathway activating activity of GRASP-1, suggesting
a novel link between Caspase-3 activation and JNK pathway sig-
naling. These results suggest that GRASP-1 serves as a scaﬀold
protein to facilitate MEKK-1 activation of JNK signaling in
neurons.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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GRASP-1 is a neuronally-enriched protein that was initially
isolated due to its interaction with the PDZ domain containing
adaptor protein glutamate receptor interacting protein
(GRIP1) [1]. GRIP1 is a neuronal scaﬀold protein [2] that
organizes protein complexes containing AMPA-type gluta-
mate receptors (AMPA-Rs), and GRASP-1 overexpression
regulates AMPA-R traﬃcking in neurons [1]. The N-terminus
of GRASP-1 is homologous to guanine nucleotide exchange
factors (GEFs) for the small GTP-binding protein Ras and
indeed GRASP-1 possesses RasGEF activity in vitro [1]. In
normal brain, a fraction of GRASP-1 is cleaved by Caspase-
3, separating the RasGEF domain from the GRIP-binding
domain. Ischemia enhances the Caspase-cleavage of GRASP-1
[3]. However, the functional signiﬁcance of Caspase-3 regula-
tion of GRASP-1 remains unknown.*Corresponding author. Fax: +1 410 955 4857.
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doi:10.1016/j.febslet.2007.08.008Ras triggers activation of several signaling pathways, most
notably the protein kinase cascade leading to activation of
the mitogen-activated protein kinase (MAPK) ERK [4]. Ras-
ERK signaling is required for several important processes in
neurons, including the regulation of dendritic morphology,
AMPA receptor traﬃcking and long term potentiation [5].
However, it is now clear that homologous MAPK pathways,
leading to the activation of cJun N-terminal kinases (JNKs)
and p38 MAPK can also regulate synaptic function [6–8].
While ERK activation in neurons, mediated via glutamate,
growth factor receptors and calcium channels, is well docu-
mented [9,10], mechanisms that control neuronal JNK activity
(which is basally very high in neurons) [11,12] are less clear.
JNKs bind, phosphorylate and activate the transcription
factor c-jun [13]. Three JNK genes have been identiﬁed, of
which JNK1 and 2 are expressed ubiquitously while JNK3 is
enriched in brain, heart, and testis [13]. JNKs are phosphory-
lated and activated by the upstream kinases SEK1/MKK4 and
MKK7. MKK4 and MKK7 are in turn phosphorylated and
activated by a variety of upstream kinases, including MEK
kinases (MEKKs; [14,15]), mixed-lineage kinases (MLKs)
and apoptosis signal-regulating kinase (ASKs; [4.13]). It is un-
clear which of these upstream kinases control neuronal JNK
activation physiologically, though data from knockout mice
demonstrate that MEKKs are essential for JNK activation
in response to certain stimuli [16].
The functions of JNKs in non-neuronal tissues are diverse,
ranging from T cell diﬀerentiation and apoptosis to tumorigen-
esis [13]. Within the brain JNKs are also implicated in a num-
ber of neurological disorders, including Parkinson’s disease,
stroke and Alzheimer’s disease [17]. However, physiological
roles for JNKs in neurons are also now being revealed, with
JNKs implicated in the regulation of dendritic morphology,
synaptic vesicle release and AMPA receptor traﬃcking
[7,8,18].
These diverse roles for JNKs in neurons suggest that diﬀer-
ent pools of JNK may exist in diﬀerent cellular locations, and
both biochemical fractionation experiments (G.M.T., R.L.H.
et al., in preparation) and the distinct phenotypes of diﬀerent
JNK knockout mice [7,18,19] support this hypothesis. The
mechanisms used by cells to diﬀerentially target JNKs to diﬀer-
ent subcellular locations are not fully clear, but attractive can-
didate mediators are various multi-domain scaﬀold proteins
that are known to bind both JNK signaling pathway compo-
nents and other proteins.
Scaﬀold proteins often bind several signaling molecules to
create multi-enzyme complexes and play important roles in
deﬁning the speciﬁcity and eﬃciency of signaling pathways.
The ﬁrst MAPK scaﬀold protein, Ste5p, was identiﬁedblished by Elsevier B.V. All rights reserved.
4404 B. Ye et al. / FEBS Letters 581 (2007) 4403–4410genetically in yeast and subsequent structure-function analysis
demonstrated that distinct regions of Ste5p interact with the
Map kinase kinase kinase (MKKK) Ste11p, the Map kinase
kinase (MKK) Ste7p and the MAP kinase Fus3p/Kss1p [4]
and that Ste5p facilitates signal transduction from Ste11p to
Fus3p/Kss1p. More recently, MAPK scaﬀold proteins have
been identiﬁed in mammalian cells. These mammalian proteins
share little sequence homology with Ste5p but function in a
similar manner. For example, JNK-interacting protein1
(JIP1) interacts with multiple components of the JNK signal-
ing pathway, including the mixed-lineage protein kinase
(MLK) family of MKKKs, MKK7 and JNK [20], and brings
upstream and downstream kinases in these cascades into close
proximity through protein–protein interactions [20,21].
Here we report that GRASP-1 functions as a JNK pathway
scaﬀold protein, binding both JNK and the upstream kinase
MEKK1 in neurons, and that these interactions facilitate
JNK signaling. We also show that the scaﬀolding function of
GRASP-1 requires Caspase-3 cleavage, which releases the
JNK/MEKK1 binding regions of GRASP-1 from the RasGEF
domain.2. Materials and methods
2.1. ERK and JNK assays on immunoprecipitates
HEK293T cells were transfected with HA-tagged ERK1 or JNK1
plus other DNA constructs of interest, using a Ca2+-phosphate meth-
od. Drug treatment and kinase assays were performed 40 h after trans-
fection. For BDNF treatment, cells were incubated in medium
containing 50 ng/ml puriﬁed BDNF for 10 min. For nocodazole treat-
ment, cells were incubated with 0.25 lg/ml nocodazole for 1 h. After
drug treatment, cells were washed once with ice-cold PBS and lysed
in ice-cold lysis buﬀer (20 mM HEPES pH 7.4, 10 mM EGTA,
40 mM b-glycerophosphate, 1% Triton X-100, 2.5 mM MgCl2, 1 mM
DTT, 2 mM sodium orthovanadate, 0.1 mM PMSF and 20 units/ml
Trasylol). ERK1 or JNK1 were immunoprecipitated from lysates with
anti-HA antibody (12CA5, Roche Molecular Biochemicals, IN) at
4 C. Immunoprecipitates were washed 3 times with TBS containing
1% Triton X-100 and 2 mM sodium orthovanadate, once with
100 mM Tris–HCl, pH 7.4 containing 0.5 M LiCl, and once with ki-
nase reaction buﬀer (25 mM HEPES, pH 7.4, with 10 mM Mg acetate
and 1 mM DTT). Reaction mix (50 ll) was added to the immunopre-
cipitates, which were then incubated at 30 C for 20 min. For the ERK
assay, reaction mix contained 1 lCi 32P-c-ATP, 20 lM ATP and
0.5 mg/ml MBP in kinase reaction buﬀer. For the JNK assay, reaction
mix contained 5 lCi 32P-c-ATP, 20 lM ATP and 2 lg GST-cJun (1–
169) in reaction buﬀer. Reactions were stopped by the addition of
10 ll of 0.5 M EDTA. 32P radioactivity incorporated into substrates
was analyzed either by spotting reaction mix onto P81 ﬁlter paper fol-
lowed by extensive washing and Cerenkov counting, or by SDS–PAGE
and subsequent autoradiography. A small fraction of each sample was
used for SDS–PAGE and subsequent immunoblotting to determine the
relative amount of HA-ERK1 and HAJNK1 in the immunoprecipi-
tates.2.2. Cell transfection and co-immunoprecipitation
HEK293 cells were transfected with HA-tagged JNK1 or MEKK1
together with various Myc-tagged GRASP-1 constructs. A region of
rat MEKK1 (between E1206 and the stop codon [22]) that is slighter
larger than the kinase domain was tagged with a HAtag at the N-ter-
minus and used in co-immunoprecipitation experiments to examine the
GRASP1–MEKK1 interaction. Mouse MEKK1 full length with an N-
terminal HA-tag was used in all other experiments. Forty-eight hours
later, cells were lysed in immunoprecipitation buﬀer (IPB: 1xPBS, 1%
Triton X-100, PMSF and aprotinin) and centrifuged at 12,000·g to
pellet insoluble material. The soluble fraction was incubated with
anti-HA antibody and Protein A-sepharose (1:1 slurry) for 2 h at
4 C. The mixture was then washed once with IPB, twice with IPB plus500 mM NaCl, and three times with IPB without Triton X-100.
Proteins were eluted with Laemmli sample buﬀer and loaded onto
SDS–polyacrylamide gels. Western analysis was performed with anti-
Myc antibody.
2.3. Detection of ERK and JNK activation using phospho-speciﬁc
antibodies
HEK293T cells transfected with various GRASP-1 or MEKK1 con-
structs were washed with ice-cold 1X PBS and lysed as for ERK and
JNK assays on immunoprecipitates. After centrifugation at 12,000·g
for 15 min, supernatants were denatured with Laemmli sample buﬀer,
separated by 10% SDS–PAGE and transferred to PVDF membrane.
The membrane was blocked with blocking buﬀer (1X PBS, 1% BSA
and 0.1% Tween-20) and then incubated with anti-phospho-ERK1/2
(Cell Signaling Technology) or anti-phospho-JNK (Cell Signaling
Technology) antibodies diluted with blocking buﬀer. After three
washes with blocking buﬀer, the membrane was incubated with perox-
idase-linked anti-mouse IgG or anti-rabbit IgG secondary antibodies
and subsequently visualized using enhanced chemiluminescence. To
normalize phosphorylation levels to JNK expression levels, we
stripped anti-phospho-JNK antibody from the Western Blot and
probed again with an antibody against JNK (Cell Signaling Technol-
ogy). The intensity of phospho-JNK (Ip) and total JNK (It) signals
were quantiﬁed with the software ImageJ (National Institutes of
Health, Bethesda, Maryland). Because the anti-JNK antibody recog-
nizes JNK2/3 (54 kD) much better than JNK1 (46 kD), the quantiﬁca-
tion was performed on JNK2/3. In all the experiments described in this
paper, phosphorylation of JNK1 always parallels that of JNK2/3. The
equation Ip · 100/It was used to calculate the normalized level of JNK
phosphorylation.3. Results
3.1. Overexpression of GRASP-1 activates the JNK pathway
GRASP-1 acts as a guanine nucleotide exchange factor for
the small GTP binding protein Ras in vitro [1] and Ras signal-
ing is known to mediate ERK activation [4]. We therefore
investigated whether expression of GRASP-1 in heterologous
cells triggered increases in ERK activity. HA-tagged ERK1
was co-transfected into HEK 293T cells plus either empty vec-
tor, an N-terminal fragment of GRASP-1 encoding the region
upstream of the Caspase-cleavage site (GRASP1-N), a C-ter-
minal fragment of GRASP-1 encoding the region downstream
of the Caspase-cleavage site (GRASP1-C) or full length
GRASP-1 containing a wild-type Caspase-cleavage site
(w.t.). ERK activity was then examined by speciﬁc immuno-
precipitation and subsequent in vitro kinase assays. Although
GRASP-1 acts as a Ras guanine nucleotide exchange factor
(Ras-GEF) in vitro, none of the GRASP-1 constructs acti-
vated ERK in HEK 293 cells (Fig. 1A). ERK was dramatically
activated by BDNF in cells transfected with the receptor tyro-
sine kinase TrkB, conﬁrming the ﬁdelity of our ERK assay.
Moreover, GRASP-1 constructs had no eﬀect on BDNF-
induced ERK activation (Fig. 1B).
Surprisingly, when similar assays were performed to assess
activation of JNK, a MAP kinase homologous to ERK, we
found that transfected HA-JNK1 was activated more than
10-fold in GRASP-1 transfected cells compared to cells trans-
fected with empty vector. Furthermore, the GRASP1-C frag-
ment was suﬃcient for this activation (Fig. 1C), while exp-
ression of the N-terminal fragment of GRASP-1 (GRASP1-N,
which contains the RasGEF domain) did not lead to JNK
activation.
To explore the mechanism of GRASP-1-induced JNK path-
way activation, we next examined whether the phosphoryla-
tion of JNK at threonine 183 (Thr183) and tyrosine 185
Fig. 1. GRASP-1 activates the JNK signaling pathway. (A) GRASP-1 does not activate ERK signaling. The histogram shows the quantiﬁcation of
results from ERK assay on immunoprecipitates of HA-ERK1. HEK293T cells were transfected with HAtagged ERK1 together with empty vector
pRK5, a plasmid encoding the receptor tyrosine kinase TrkB, the region of GRASP-1 upstream of the caspase-cleavage site (N), the region of
GRASP-1 downstream of the caspase-cleavage site (C) or GRASP-1 wild-type full-length (w.t.). TrkB-transfected cells were treated with 50 ng/ml
puriﬁed BDNF for 10 min prior to the assay. Kinase activity towards the ERK substrate MBP was analyzed following immunoprecipitation with HA
antibody and is plotted relative to control (empty vector transfected) cells. Western blotting analysis with anti-HA antibody conﬁrmed similar
amounts of HA-ERK1 in immunoprecipitates (data not shown). (B) GRASP-1 does not enhance TrkB-mediated ERK activation. HEK293T cells
transfected with HA-tagged ERK1 and TrkB cDNAs together with empty vector pRK5, or GRASP-1-N, GRASP-1-C or GRASP-1 wild-type full-
length (w.t.) cDNAs. Every dish of transfected cells was treated with 50 ng/ml puriﬁed BDNF for 10 min prior to lysis and assay as in (A). (C)
GRASP-1 activates JNK signaling. HA immunoprecipitation and subsequent kinase assay using GST-cJun as substrate was performed using lysates
from HEK293T cells co-transfected with HA-JNK1 plus the GRASP-1 constructs described in (A). One dish of cells transfected with empty vector
was treated with 0.25 lg/ml nocodazole for 1 h and used as positive control for JNK activation. (D) Time course of JNK phosphorylation at Thr183/
Tyr185 promoted by GRASP-1 C-terminal fragment (GRASP1-C). HEK293T cells were transfected with either empty plasmid vector or GRASP1-C
plasmids. Cell lysates were collected at diﬀerent time points following transfection as indicated. Representative Western Blot is shown for 36 h after
transfection. The plot shows the levels of JNK phosphorylation normalized to the levels of JNK protein.
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ation of Thr183 and Tyr185 by SEK1/MKK4, which is in turn
phosphorylated and activated by several kinases including
MEKK1, is known to activate JNK1/2/3 [4,15]. We found that
expression of GRASP1-C robustly increased JNK phosphory-
lation (Fig. 1D). The GRASP-1-induced increase in JNK
phosphorylation was detectable 12 h after transfection and
reached a plateau about 36 h after transfection (Fig. 1D).These results suggest that the region of GRASP-1 downstream
of the Caspase-3-cleavage site is capable of activating the JNK
signaling pathway by enhancing the phosphorylation of JNK.
3.2. GRASP-1 interacts with MEKK1 and JNK1
Scaﬀold proteins, such as JIP-1, activate the JNK pathway by
bringing upstream and downstream kinases in these cascades
into close proximity through protein–protein interactions
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vate JNK signaling might be due to its ability to act as a scaﬀold
of this type and therefore examined whether JNK directly inter-
acts with GRASP-1. Indeed, JNK1 was clearly detected in myc
immunoprecipitates from HEK293T cells co-expressing
myc-GRASP-1 and HA-JNK1, but not from cells expressing
HA-JNK1 alone (Fig. 2A). Since JIP1-like scaﬀolds also bindFig. 2. GRASP-1 interacts with MEKK1 and JNK1. (A) JNK1 coimmunop
cells were co-transfected with Myc-tagged GRASP-1 and HA-tagged JN
immunoprecipitated with anti-myc antibody and the immunoprecipitates we
lysate from each transfection (Input) was examined for expression of Myc-
transfected HEK293T cells. HEK293T cells were co-transfected with Myc-t
GRASP-1 alone or HA-MEKK1 alone. Lysates were immunoprecipitated w
immunoblotting with anti-HA antibody. A fraction of lysate from each tra
GRASP-1 is present in MEKK1 and JNK1 immunoprecipitates from cortical
was performed with the indicated antibodies and the immunoprecipitates we
MEKK1-induced JNK phosphorylation. The upper panel shows a represent
from 3 independent experiments. **: P < 0.01 (t-test).upstream JNK pathway kinases [20] we also examined the abil-
ity of GRASP-1 to interact with MEKK1, a well-characterized
JNK pathway ‘upstream’ kinase [4,15]. HEK293T cells were
therefore transfected with HA-tagged MEKK1, Myc-tagged
GRASP1-C, or these two constructs together, and immuno-
precipitations were performed from cell lysates using anti-HA
antibody. GRASP1-C was detected in HA immunoprecipitatesrecipitates with GRASP-1 from transfected HEK293T cells. HEK293T
K1 or Myc-GRASP-1 alone or HA-MEKK1 alone. Lysates were
re analyzed by immunoblotting with anti-HA antibody. A fraction of
GRASP-1. (B) MEKK1 co-immunoprecipitates with GRASP-1 from
agged GRASP-1 and HA-tagged kinase domain of MEKK1 or Myc-
ith anti-myc antibody and the immunoprecipitates were analyzed by
nsfection (Input) was examined for expression of Myc-GRASP-1. (C)
neuronal cultures. Immunoprecipitation from cortical neuronal lysates
re examined for the presence of GRASP-1. (D) GRASP1-C enhances
ative Western Blot. The histogram shows the quantiﬁcation of results
B. Ye et al. / FEBS Letters 581 (2007) 4403–4410 4407only in lysates from cells co-transfected with HA-MEKK1 and
GRASP1-C (Fig. 2B). These experiments demonstrated that
GRASP-1 interacts with two key kinases in the JNK pathway.
To examine whether GRASP-1 interacts with MEKK1 and
JNK1 in neurons, co-immunoprecipitation experiments were
performed with detergent-solubilized extracts from cultured
cortical neurons (Fig. 2C). Both antiJNK1 and anti-MEKK1
antibodies immunoprecipitated GRASP-1 from neuronal
lysates while antibodies against Myc, against the NR1 subunit
of NMDA receptors or against ERK1 did not immunoprecip-
itate GRASP-1. These results suggest that GRASP-1 interacts
with MEKK1 and JNK1 in neurons.
3.3. GRASP-1 is a scaﬀold protein for the JNK signaling
pathway
While the results above suggested that GRASP-1 can bind
JNK1 and MEKK1 in both heterologous cells and neurons,
they did not address whether GRASP-1 acts as a JNK path-Fig. 3. GRASP-1 serves as a scaﬀold protein for the JNK signaling pathway
MEKK1- and JNK interaction sites were mapped by coimmunoprecipitation
HA-JNK1 plus the indicated truncation or internal deletion mutants of GRA
appeared to interact with two sites in the C-terminal fragment and the interact
deﬁcient in JNK (D6) and/or MEKK1 binding (D6–D12) do not activate JNK
lysates from HEK293T cells transfected with empty vector pRK5, GRASP1
treatment on cells transfected with pRK5 was used as a positive control.way scaﬀold and facilitates activation of JNK signaling. To
begin to explore this possibility, we examined whether co-
expression of GRASP-1 augments JNK activation by MEKK1
(which when transfected alone is known to activate JNK
signaling [4,15]). Indeed, HEK293T cells transfected with the
C-terminal fragment of GRASP-1 together with MEKK1 dis-
played a greater degree of JNK activation than cells transfec-
ted with either construct alone (Fig. 2D), consistent with the
hypothesis that GRASP-1 acts as a scaﬀold protein for JNK
pathway kinases.
An alternative interpretation of this result, however, is that
GRASP-1 and MEKK1 activate JNK via separate parallel
pathways. To distinguish between these possibilities, we
mapped the regions of GRASP-1 that are required for
MEKK1 and JNK1 binding. These MEKK1- and JNK-inter-
action sites were mapped by coimmunoprecipitation using
serial truncation and internal deletion mutants of GRASP-1
(Fig. 3A). Deletion of a 16 amino acid sequence within the. (A) Mapping of the MEKK1- and JNK1-binding sites in GRASP-1.
studies using HEK293T cells co-transfected with either HA-MEKK1 or
SP-1. The D6 deletion abolished the interaction with JNK1. MEKK-1
ion existed until both D6 and D12 were deleted. (B) GRASP-1 mutants
. Western analysis was performed with anti-phospho-Jun antibody on
-N, GRASP1-C, GRASP1-CD6 or GRASP1-CD6–D12. Nocodazole-
4408 B. Ye et al. / FEBS Letters 581 (2007) 4403–4410linker region of GRASP1 (D6) abolished the interaction with
JNK1. MEKK-1 required two sites in the C-terminal fragment
of GRASP-1, one within the RBD and the second in the D6
linker region, and the interaction was maintained until both
D6 and a 13 amino acid sequence (D12) were deleted (Fig. 3A).
The GRASP-1 deletion mutants were then tested for their
ability to activate JNK. Interestingly, both D6 and D6–D12
mutants of GRASP-1 caused greatly reduced activation of
JNK compared to that caused by the C-terminal fragment
(Fig. 3B), suggesting that JNK pathway activation by
GRASP-1 requires interactions of GRASP-1 with JNK and
MEKK1. These results support the hypothesis that GRASP-
1 serves as a scaﬀold protein that can lead to the activation
of the JNK signaling pathway.
3.4. Caspase-3-cleavage is required for GRASP-1-mediated
JNK pathway activation
GRASP-1 is one of the few neuron-speciﬁc substrates of
Caspase-3. The cleavage of GRASP-1 by Caspase-3 releases
the 30 kDa C-terminal fragment (GRASP1-C) from the rest
of the protein [1,3]. This cleavage event occurs in both normalFig. 4. Caspase-3-cleavage is required for GRASP-1-mediated JNK pathway
3 cleavage site (F.L.-D/E) is a much less eﬀective activator for JNK signaling.
of Myc-GRASP1-F.L.-D/E and Myc-GRASP1-C. n.s: not signiﬁcant. N
phosphorylation. *: P < 0.05 (t-test), n = 3. (C) A model that summarizes our
pathway.brain and ischemic brain [3]. Western Blot analysis with anti-
bodies against the C-terminal region of GRASP-1 suggests
that a signiﬁcant amount of the GRASP1-C fragment is pres-
ent in normal brain [1] as well as in HEK293T cells (data not
shown). However, the functional signiﬁcance of this cleavage is
unknown. Since the JNK pathway activating activity of
GRASP-1 is unique to the GRASP1-C fragment, we wondered
whether Caspase-3-cleavage of GRASP-1 played a role in reg-
ulating this activity.
To examine this possibility, we compared the level of JNK
phosphorylation in cells expressing GRASP1-C and those
expressing a full length GRASP-1 that is resistant to Cas-
pase-3 cleavage due to mutations in the cleavage site (F.L.-
D/E) [1]. The amount of Myc-tagged GRASP1-C and
GRASP-F.L.-D/E cDNA that was transfected was adjusted
so these two proteins were expressed at comparable levels
(Fig. 4A). Strikingly, while GRASP1-C dramatically enhanced
JNK phosphorylation, GRASP1-F.L-D/E did not signiﬁcantly
alter JNK phosphorylation (Fig. 4B). Taken together, these re-
sults suggest that full length GRASP-1 does not enhance JNK
pathway activity, possibly due to the inhibitory eﬀect of the N-activation. (A, B) Full length GRASP-1 containing a mutated Caspase-
(A) Western Blot and quantiﬁcation show comparable expression levels
= 3. (B) GRASP1-C but not GRASP1-F.L.-D/E enhances JNK
ﬁndings that GRASP-1 serves as a scaﬀold protein for JNK signaling
B. Ye et al. / FEBS Letters 581 (2007) 4403–4410 4409terminal fragment on the C-terminal fragment. In contrast,
Caspase-3 cleavage of GRASP-1 releases the C-terminal frag-
ment, which in turn activates JNK signaling by serving as a
scaﬀold protein (Fig. 4C).4. Discussion
In this study, we have demonstrated that GRASP-1 serves as
a neuronal scaﬀold protein for the JNK signaling pathway. We
have also provided evidence that this function of GRASP-1 is
regulated by Caspase-3.
Although GRASP-1 acts as a RasGEF in vitro [1], we did
not observe GRASP-1-dependent activation of ERK (a well-
known ‘downstream’ target of Ras) in HEK293T cells. There
are several possible explanations for this ﬁnding. Firstly, the
Ras superfamily of small G proteins contains many members
and the speciﬁc Ras that is regulated by GRASP-1 in vivo
may not be expressed in HEK293T cells. Furthermore, a sig-
niﬁcant fraction of GRASP-1 localizes to speciﬁc intracellular
vesicles [1] that are likely to be endosomes [23]. Diﬀerent small
G proteins localize to speciﬁc cellular membranes [24] and it is
possible that in HEK293T cells the localization of GRASP-1 is
distinct from that of Ras family proteins that GRASP-1 has
the ability to regulate in vitro. A further possibility is that
additional GRASP-1 binding partners (including JNK path-
way kinases) might sterically obscure the Ras binding domain
(RBD) of GRASP-1 in cells, thus limiting GRASP-1’s ability
to function as a RasGEF. It will be interesting to investigate
whether stimuli that induce changes in GRASP-1 localization
and/or regulate GRASP-1’s interactions with its binding part-
ners might diﬀerentially modulate the ability of GRASP-1 to
modulate Ras, JNK and AMPA receptors.
Accumulating evidence suggests that glutamate receptors
activate signal transduction through kinase cascades in neu-
rons. For example, glutamate treatment [9] and membrane
depolarization [10,25] activate ERK signaling through Ras in
a calcium dependent manner. In contrast, JNK activity in neu-
rons is constitutively high [11] but speciﬁc pools of JNK can
respond to certain stimuli [12]. Subcellular fractionation exper-
iments reveal GRASP-1 immunoreactivity in both post-synap-
tic density and cytosolic fractions [1]. Whether GRASP-1/JNK
pathway complexes contribute to synaptic or cytosolic JNK
activity, or to both is an intriguing problem to solve in future.
We note that JNK plays many roles in neurons in diﬀerent
subcellular locations and is known to interact with a variety
of scaﬀold proteins. It is therefore not surprising that only a
small fraction of the total pool of JNK is complexed with
GRASP-1 in neurons (Fig. 2C). However, even if JNK–
GRASP-1 complexes comprise only a minor fraction of total
JNK scaﬀold complexes, JNK–GRASP-1 complexes might
still play a critical role in certain subcellular locations, or in
response to particular stimuli.
One set of stimuli that might regulate JNK–MEKK1–
GRASP-1 complexes are those that induce Caspase activation.
We have previously demonstrated that GRASP-1 is a direct
Caspase-3 substrate [1,3]. Here we demonstrate that the Cas-
pase-3 cleavage of GRASP-1 is necessary for the ability of
GRASP-1 to enhance JNK pathway activity.
Interestingly, MEKK-1 is also a substrate of Caspase-3 and
cleavage of MEKK-1 by Caspase-3 results in subsequent
kinase activation [26]. Not only are both MEKK-1 andGRASP-1 Caspase-3 substrates, the cleavage sites of these
two proteins are more homologous to each other than to any
other Caspase-3 substrates, suggesting that Caspase-3 may
bind GRASP-1 and MEKK-1 with similar aﬃnity, and that
their cleavage might be triggered under similar conditions.
Cleavage of MEKK-1 by Caspase-3 is required for the apopto-
sis induced by loss of integrin-mediated contacts with the
extracellular matrix (‘‘anoikis’’) in MDCK cells [27] and geno-
toxin-induced apoptosis in HEK293 cells [28]. Roles for
MEKK-1 have also been reported in apoptosis of neuro-
nally-derived cell lines [29,30]. The functions of MEKK-1
can be either JNK-dependent or JNK-independent. For exam-
ple, apoptosis mediated by MEKK-1 in rat PC12 pheochromo-
cytoma cells is JNK-dependent, while MEKK-1-mediated
apoptosis in Swiss 3T3 cells is JNK-independent [30,31]. In
neurons, prolonged activation of AMPA receptors leads to
JNK pathway activation (B.Y. and R.L.H, unpublished re-
sults) and delayed neuronal cell death [32]. In addition, multi-
ple forms of neuronal cell death including cerebral ischemia
and kainate-induced excitotoxicity require JNK [17,19]. Given
the fact that GRASP-1 scaﬀolds JNK with MEKK1, and
MEKK1 is an apoptosis inducing kinase, it is conceivable that
the JNK activation facilitated by GRASP-1 has apoptotic
eﬀects. It is an intriguing possibility that during neuronal apop-
tosis, JNK pathway activity may be enhanced not only by the
activation ofMEKK1 by Caspase-3 cleavage but also by the re-
lease of the GRASP-1 C-terminal fragment, which then serves
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